Analytical Data
-
基因名
AKR7A3
- Application
-
别名
AFB1 aldehyde reductase 2
-
种属
Human
-
表达系统
E. coli
-
标签
N- GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O95154
-
表达区间
1-331aa
-
分子量
64.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AKR7A3 (aldo-keto reductase family 7 member A3) is an enzyme that belongs to the aldo-keto reductase superfamily, which is involved in the reduction of aldehydes and ketones to their corresponding alcohols. This protein plays a critical role in various physiological processes, including lipid metabolism, detoxification, and the protection against oxidative stress. Recent studies have indicated that AKR7A3 may be implicated in pathological conditions such as cancer and metabolic disorders, highlighting its potential as a therapeutic target. Research has focused on the recombinant expression of AKR7A3 to better understand its enzymatic properties, structure, and function, as well as to explore its role in drug metabolism and disease progression. Understanding the molecular mechanisms of AKR7A3 could provide insights into its function in health and disease, paving the way for novel interventions in treating related conditions. Given the increasing prevalence of diseases linked to metabolic dysregulation and oxidative stress, the study of AKR7A3 recombinant protein offers significant potential for both basic research and therapeutic applications.
